Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 151,200 shares at $134.34 ($20.6M) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Seasonal sale ($20.6M) by Chief Executive Officer — this insider has traded MRNA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.34 | 11,319 | $1.5M | 7.4% |
| 2 | $134.34 | 11,319 | $1.5M | 7.4% |
| 3 | $135.26 | 21,938 | $3.0M | 14.4% |
| 4 | $135.26 | 21,938 | $3.0M | 14.4% |
| 5 | $136.17 | 5,593 | $762K | 3.7% |
| 6 | $136.17 | 5,593 |
| $762K |
| 3.7% |
| 7 | $137.03 | 1,150 | $158K | 0.8% |
| 8 | $137.03 | 1,150 | $158K | 0.8% |
| 9 | $136.44 | 8,700 | $1.2M | 5.8% |
| 10 | $137.42 | 17,541 | $2.4M | 11.7% |
| 11 | $137.42 | 17,541 | $2.4M | 11.7% |
| 12 | $138.27 | 13,659 | $1.9M | 9.2% |
| 13 | $138.27 | 13,659 | $1.9M | 9.2% |
| 14 | $139.03 | 100 | $14K | 0.1% |
| Total | $136.33 avg | 151,200 | $20.6M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |